Volume : 09, Issue : 07, July – 2022
51.DEVELOPMENT AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY FOR ENHANCEMENT OF BIOAVAILABILITY OF LINAGLIPTIN
Dr. Parul Mehta, Ms. Kajal Sharama, Anshu Patel*
Diabetes mellitus is a serious and spreading health issue that is a significant contributor to early death and chronic illness. It is a long-term metabolic condition defined by chronic insulin resistance and high blood glucose levels (hyperglycemia) brought on by insulin insufficiency. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is frequently prescribed to treat type 2 diabetes. Although Linagliptin has a low bioavailability (30%) due to its poor penetration profile and low water solubility. Furthermore, the requirement to maintain stable plasma concentrations for efficient long-term blood sugar control in diabetic patients supports the need for transdermal delivery of linagliptin. Transdermal matrix patches were created, and it was determined that the matrix kind of patches were suitable. The optimal formulation of the various matrix types (F1 to F6) was decided to be F5, which contains Eudragit RSPO and HPMC. It was also discovered that the drug permeation profile followed zero order kinetics. The patches were translucent, thin, and flexible. The current investigation revealed that Linagliptin matrix transdermal patches performed better in vitro than pure medication.
Key words: Diabetes mellitus, Linagliptin, Transdermal matrix patches, Formulation, Evaluation.
Cite This Article:
Please cite this article in press Anshu Patelet al,Development And Characterization Of Transdermal Drug Delivery For Enhancement Of Bioavailability Of Linagliptin.,Indo Am. J. P. Sci, 2022; 09(7).,
Number of Downloads : 10
1. Jhawat VC, et al. “Transdermal drug delivery systems: approaches and advancements in drug absorption through skin.” Int J Pharm Sci Rev Res. 2013; 20(1):47-56.
2. Bhowmik D, Dasari V, Duraivel S, Sampath Kumar KP. Recent Trends in Penetration Enhancer Used In Transdermal Drug Delivery System. The Pharma Innovation – Journal. Feb 2013; 2: 127-134.
3. Sharma A, Saini S, Rana AC, Transdermal Drug Delivery System: A Review. International Journal of research in pharmaceutical and biomedical sciences. 2013; 4(1):286-292.
4. Mezei M. Liposomes as penetration promoters and localizers of topically applied drugs. In Drug Permeation Enhancement: Theory and Applications, Hsieh, D.S., Ed.; Marcel Dekker: New York, NY, USA, 1994; pp. 171-198.
5. Ghafourian, T.; Samaras, E.G.; Brooks, J.D.; Riviere, J.E. Validated models for predicting skin penetration from different vehicles. Eur. J. Pharm. Sci. 2010; 41:612-616.
6. Anuradha Patel, Richa Solanki, Saumya Jain, Yuvraj Singh Dangi, Naina Dubey. Formulation, Development and Evaluation of Etoricoxib containing Transdermal patches in Arthritis management. International Journal of Research and Analytical Reviews. 2018; 5(4):242-249.
7. Cherukuri S, Batchu UR, Mandava K, Cherukuri V, Ganapuram KR. Formulation and evaluation of transdermal drug delivery of topiramate. Int J Pharma Investig 2017;7:10-7.
8. Anroop B Nair, Rachna Kumria, Bandar E Al-Dhubiab, Mahesh Attimarad and Sree Harsha. Development of Transdermal Delivery System of Vildagliptin and Its Comparison with Oral Therapy. Indian Journal of Pharmaceutical Education and Research. 2016; 50(1):130-137.
9. Amandeep Singh and Alka Bali. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. Journal of Analytical Science and Technology (2016) 7:25.
10. Nimesh Goswami, Paresh Prajapati. Formulation development and evaluation of matrix type lidocaine topical patch for local anesthetic. International Journal of Research and Development in Pharmacy and Life Sciences. 2016; 5(1): 1963-1973.
11. Xiaoping Zhan, Zhenmin Mao, Sijing Chen, Shaoxiong Chen, Liqun Wang.
Formulation and evaluation of transdermal drug-delivery system of isosorbide dinitrate. Brazilian Journal of Pharmaceutical Sciences. 2015; 51(2): 374-382.
12. Rajesh Asija, Avinash Gupta and Bhagwan Swaroop Maheshwari. Formulation and evaluation of Transdermal patches of Torasemide. International Journal of Advances in Scientific Research 2015; 1(01): 38-44.